Invention Grant
- Patent Title: Methods and compositions for live attenuated viruses
-
Application No.: US15194297Application Date: 2016-07-22
-
Publication No.: US10525120B2Publication Date: 2020-01-07
- Inventor: Dan Stinchcomb , Jorge E. Osorio , O'Neil Wiggan
- Applicant: Takeda Vaccines, Inc.
- Applicant Address: US MA Cambridge
- Assignee: TAKEDA VACCINES, INC.
- Current Assignee: TAKEDA VACCINES, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Nath, Goldberg & Meyer
- Agent Joshua B. Goldberg; Scott H. Blackman
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K47/26 ; A61K47/42 ; C12N7/00 ; C08L71/02 ; A61K47/36 ; A61K39/00
Abstract:
Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
Public/Granted literature
- US20170100474A1 METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES Public/Granted day:2017-04-13
Information query
